{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:24:27Z","timestamp":1792765467982,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["12642"],"award-info":[{"award-number":["12642"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"DOI":"10.1186\/s12911-025-03166-6","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:24:14Z","timestamp":1759155854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluating the effectiveness of a risk prediction model (PERSARC) on improving treatment decisions quality for patients with soft-tissue sarcomas: the VALUE-PERSARC study"],"prefix":"10.1186","volume":"25","author":[{"given":"Anouk A.","family":"Kruiswijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perla J. Marang-van","family":"de Mheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A. E.","family":"Vlug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen G.","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Fiocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick L.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne M.","family":"Schrage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc H. A.","family":"Bemelmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"van Ginkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes J.","family":"Bonenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjen J.","family":"Witkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel A. J.","family":"van de Sande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leti","family":"van Bodegom-Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"VALUE-PERSARC research group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"3166_CR1","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics. CA Cancer J Clin. 2021;71(1): pp. 7\u201333.","DOI":"10.3322\/caac.21654"},{"issue":"3","key":"3166_CR2","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ejca.2012.09.011","volume":"49","author":"CA Stiller","year":"2013","unstructured":"Stiller CA, Trama A, Serraino D, Rossi S, Navarro C, Chirlaque MD, Casali PG, Grp RW. Descriptive epidemiology of sarcomas in europe: report from the RARECARE project. Eur J Cancer. 2013;49(3):684\u201395.","journal-title":"Eur J Cancer"},{"issue":"3","key":"3166_CR3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1200\/JCO.1996.14.3.869","volume":"14","author":"JM Coindre","year":"1996","unstructured":"Coindre JM, Terrier P, Bui NB, Bonichon F, Collin F, Doussal VL, Mandard AM, Vilain MO, Jacquemier J, Duplay H, et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French federation of cancer centers sarcoma group. J Clin Oncol. 1996;14(3):869\u201377.","journal-title":"J Clin Oncol"},{"issue":"3","key":"3166_CR4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0360-3016(03)00714-4","volume":"57","author":"GK Zagars","year":"2003","unstructured":"Zagars GK, Ballo MT, Pisters PWT, Pollock RE, Patel SR, Benjamin RS. Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial Conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2003;57(3):739\u201347.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"3166_CR5","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1200\/JCO.1996.14.3.859","volume":"14","author":"PW Pisters","year":"1996","unstructured":"Pisters PW, Harrison LB, Leung DH, Woodruff JM, Casper ES, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 1996;14(3):859\u201368.","journal-title":"J Clin Oncol"},{"issue":"5","key":"3166_CR6","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00264-015-2694-x","volume":"39","author":"JJ Willeumier","year":"2015","unstructured":"Willeumier JJ, Fiocco M, Nout R, Dijkstra S, Aston W, Pollock R, Hartgrink H, Bovee J, van de Sande M. High-grade soft tissue sarcomas of the extremities: surgical margins influence only local recurrence not overall survival. Int Orthop. 2015;39(5):935\u201341.","journal-title":"Int Orthop"},{"issue":"7","key":"3166_CR7","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.ejso.2016.02.004","volume":"42","author":"DA Muller","year":"2016","unstructured":"Muller DA, Beltrami G, Scoccianti G, Frenos F, Capanna R. Combining limb-sparing surgery with radiation therapy in high-grade soft tissue sarcoma of extremities - Is it effective? Ejso. 2016;42(7):1057\u201363.","journal-title":"Ejso"},{"issue":"2","key":"3166_CR8","doi-asserted-by":"publisher","first-page":"e012930","DOI":"10.1136\/bmjopen-2016-012930","volume":"7","author":"JJ Willeumier","year":"2017","unstructured":"Willeumier JJ, Rueten-Budde AJ, Jeys LM, Laitinen M, Pollock R, Aston W, Dijkstra PD, Ferguson PC, Griffin AM, Wunder JS, et al. Individualised risk assessment for local recurrence and distant metastases in a retrospective transatlantic cohort of 687 patients with high-grade soft tissue sarcomas of the extremities: a multistate model. BMJ Open. 2017;7(2):e012930.","journal-title":"BMJ Open"},{"issue":"18","key":"3166_CR9","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1002\/cncr.28793","volume":"120","author":"PW O\u2019Donnell","year":"2014","unstructured":"O\u2019Donnell PW, Griffin AM, Eward WC, Sternheim A, Catton CN, Chung PW, O\u2019Sullivan B, Ferguson PC, Wunder JS. The effect of the setting of a positive surgical margin in soft tissue sarcoma. Cancer. 2014;120(18):2866\u201375.","journal-title":"Cancer"},{"issue":"12","key":"3166_CR10","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1002\/cncr.26489","volume":"118","author":"R Dagan","year":"2012","unstructured":"Dagan R, Indelicato DJ, McGee L, Morris CG, Kirwan JM, Knapik J, Reith J, Scarborough MT, Gibbs CP, Marcus RB, et al. The significance of a marginal excision after preoperative radiation therapy for soft tissue sarcoma of the extremity. Cancer. 2012;118(12):3199\u2013207.","journal-title":"Cancer"},{"issue":"4","key":"3166_CR11","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.ijrobp.2009.06.074","volume":"77","author":"A Al Yami","year":"2010","unstructured":"Al Yami A, Griffin AM, Ferguson PC, Catton CN, Chung PWM, Bell RS, Wunder JS. O\u2019Sullivan, Positive surgical margins in soft tissue sarcoma treated with preoperative radiation: is a postoperative boost necessary? Int J Radiation Oncology*Biology*Physics. 2010;77(4):1191\u20137.","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"issue":"2","key":"3166_CR12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3892\/or.2016.4862","volume":"36","author":"K Harati","year":"2016","unstructured":"Harati K, Kirchhoff P, Behr B, Daigeler A, Goertz O, Hirsch T, Lehnhardt M, Ring A. Soft tissue sarcomas of the distal lower extremities: A single-institutional analysis of the prognostic significance of surgical margins in 120 patients. Oncol Rep. 2016;36(2):863\u201370.","journal-title":"Oncol Rep"},{"key":"3166_CR13","doi-asserted-by":"crossref","unstructured":"Hoefkens F, Dehandschutter C, Somville J, Meijnders P, Van Gestel D. Soft tissue sarcoma of the extremities: pending questions on surgery and radiotherapy. Radiat Oncol. 2016;11.","DOI":"10.1186\/s13014-016-0668-9"},{"issue":"1","key":"3166_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/0272989X08327067","volume":"29","author":"A LeBlanc","year":"2009","unstructured":"LeBlanc A, Kenny DA, O\u2019Connor AM, Legare F. Decisional conflict in patients and their physicians: A dyadic approach to shared decision making. Med Decis Making. 2009;29(1):61\u20138.","journal-title":"Med Decis Making"},{"key":"3166_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/0272989X9501500105","volume":"15","author":"AM O\u2019Connor","year":"1995","unstructured":"O\u2019Connor AM. Validation of the decisional conflict scale. Med Decis Making. 1995;15:25\u201330.","journal-title":"Med Decis Making"},{"issue":"1","key":"3166_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40271-019-00381-y","volume":"13","author":"JL Pablos","year":"2020","unstructured":"Pablos JL, Jover JA, Roman-Ivorra JA, Inciarte-Mundo J, Dilla T, Sacristan JA, Comellas M, Lizan L. Patient decision aid (PDA) for patients with rheumatoid arthritis reduces decisional conflict and improves readiness for treatment decision making. Patient-Patient Centered Outcomes Res. 2020;13(1):57\u201369.","journal-title":"Patient-Patient Centered Outcomes Res"},{"issue":"3","key":"3166_CR17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1200\/JCO.2013.50.3417","volume":"32","author":"EG Engelhardt","year":"2014","unstructured":"Engelhardt EG, Garvelink MM, de Haes JCJM, van der Hoeven JJM, Smets EMA, Pieterse AH, Stiggelbout AM. Predicting and communicating the risk of recurrence and death in women with Early-Stage breast cancer: A systematic review of risk prediction models. J Clin Oncol. 2014;32(3):238\u2013.","journal-title":"J Clin Oncol"},{"key":"3166_CR18","doi-asserted-by":"crossref","unstructured":"Rueten-Budde AJ, van de Sande MAJ, van Praag VM. M. Fiocco and P. study-group, External validation and adaptation of a dynamic prediction model for patients with high-grade extremity soft tissue sarcoma. J Surg Oncol. 2020.","DOI":"10.1002\/jso.26337"},{"issue":"4","key":"3166_CR19","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.suronc.2018.09.003","volume":"27","author":"AJ Rueten-Budde","year":"2018","unstructured":"Rueten-Budde AJ, van Praag VM, studygroup P, van de Sande MAJ, Fiocco M. Dynamic prediction of overall survival for patients with high-grade extremity soft tissue sarcoma. Surg Oncol. 2018;27(4):695\u2013701.","journal-title":"Surg Oncol"},{"key":"3166_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ejca.2017.06.032","volume":"83","author":"VM van Praag","year":"2017","unstructured":"van Praag VM, Rueten-Budde AJ, Jeys LM, Laitinen MK, Pollock R, Aston W, van der Hage JA, Dijkstra PDS, Ferguson PC, Griffin AM, et al. A prediction model for treatment decisions in high-grade extremity soft-tissue sarcomas: personalised sarcoma care (PERSARC). Eur J Cancer. 2017;83:313\u201323.","journal-title":"Eur J Cancer"},{"key":"3166_CR21","doi-asserted-by":"publisher","first-page":"p8851354","DOI":"10.1155\/2021\/8851354","volume":"2021","author":"HSF Hagenmaier","year":"2021","unstructured":"Hagenmaier HSF, van Beeck AGK, Haas RL, van Praag VM, van Bodegom-Vos L, van der Hage JA, Krol S, Speetjens FM, Cleven AHG, Navas A, et al. The influence of personalised sarcoma care (PERSARC) prediction modelling on clinical decision making in a multidisciplinary setting. Sarcoma. 2021;2021:p8851354.","journal-title":"Sarcoma"},{"key":"3166_CR22","doi-asserted-by":"crossref","unstructured":"Kruiswijk AA, van de Sande MAJ, Haas RL, van den Akker-van EM, Marle EG, Engelhardt P, van Marang-van de Mheen L. Bodegom-Vos and V.-P.r. group. (Cost-)effectiveness of an individualised risk prediction tool (PERSARC) on patient\u2019s knowledge and decisional conflict among soft-tissue sarcomas patients: protocol for a parallel cluster randomised trial (the VALUE-PERSARC study). BMJ Open. 2023;13(11):e074853.","DOI":"10.1136\/bmjopen-2023-074853"},{"issue":"8","key":"3166_CR23","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jclinepi.2010.02.005","volume":"63","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D, Grp C. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010;63(8):834\u201340.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"3166_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ijc.2910330108","volume":"33","author":"M Trojani","year":"1984","unstructured":"Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, Demascarel A, Goussot JF, David M, Bonichon F, Lagarde C. Soft-Tissue sarcomas of Adults - Study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer. 1984;33(1):37\u201342.","journal-title":"Int J Cancer"},{"issue":"11","key":"3166_CR25","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1002\/pon.4782","volume":"27","author":"JAE Custers","year":"2018","unstructured":"Custers JAE, Kwakkenbos L, van de Wal M, Prins JB, Thewes B. Re-validation and screening capacity of the 6-item version of the cancer worry scale. Psycho-oncology. 2018;27(11):2609\u201315.","journal-title":"Psycho-oncology"},{"issue":"7","key":"3166_CR26","doi-asserted-by":"publisher","first-page":"e0132158","DOI":"10.1371\/journal.pone.0132158","volume":"10","author":"S Rodenburg-Vandenbussche","year":"2015","unstructured":"Rodenburg-Vandenbussche S, Pieterse AH, Kroonenberg PM, Scholl I, van der Weijden T, Luyten GP, Kruitwagen RF, den Ouden H, Carlier IV, van Vliet IM, et al. Dutch translation and psychometric testing of the 9-Item shared decision making questionnaire (SDM-Q-9) and shared decision making questionnaire-Physician version (SDM-Q-Doc) in primary and secondary care. PLoS ONE. 2015;10(7):e0132158.","journal-title":"PLoS ONE"},{"issue":"2","key":"3166_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1046\/j.1369-6513.2000.00067.x","volume":"3","author":"V Fiset","year":"2000","unstructured":"Fiset V, O\u2019Connor AM, Evans W, Graham I, DeGrasse C, Logan J. Development and evaluation of a decision aid for patients with stage IV non-small cell lung cancer. Health Expect. 2000;3(2):125\u201336.","journal-title":"Health Expect"},{"issue":"10","key":"3166_CR28","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1200\/JCO.2008.20.2119","volume":"28","author":"SS Lo","year":"2010","unstructured":"Lo SS, Mumby PB, Norton J, Rychlik K, Smerage J, Kash J, Chew HK, Gaynor ER, Hayes DF, Epstein A, et al. Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection. J Clin Oncol. 2010;28(10):1671\u20136.","journal-title":"J Clin Oncol"},{"key":"3166_CR29","unstructured":"Team RDC. R: a language and environment for statistical computing. 2009; Available from: http:\/\/www.R-project.org"},{"issue":"2","key":"3166_CR30","doi-asserted-by":"publisher","first-page":"e1001381","DOI":"10.1371\/journal.pmed.1001381","volume":"10","author":"EW Steyerberg","year":"2013","unstructured":"Steyerberg EW, Moons KG, van der Windt DA, Hayden JA, Perel P, Schroter S, Riley RD, Hemingway H, Altman DG. Prognosis research strategy (PROGRESS) 3: prognostic model research. PLoS Med. 2013;10(2):e1001381.","journal-title":"PLoS Med"},{"key":"3166_CR31","doi-asserted-by":"crossref","unstructured":"Moons K.G., Kengne A.P., Woodward M, Royston P, Vergouwe Y, Altman D.G., Grobbee D.E. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart. 2012;98(9):683\u201390.","DOI":"10.1136\/heartjnl-2011-301246"},{"key":"3166_CR32","doi-asserted-by":"publisher","first-page":"g7594","DOI":"10.1136\/bmj.g7594","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350:g7594.","journal-title":"BMJ"},{"issue":"1","key":"3166_CR33","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12874-022-01801-8","volume":"22","author":"MAE Binuya","year":"2022","unstructured":"Binuya MAE, Engelhardt EG, Schats W, Schmidt MK, Steyerberg EW. Methodological guidance for the evaluation and updating of clinical prediction models: a systematic review. BMC Med Res Methodol. 2022;22(1):316.","journal-title":"BMC Med Res Methodol"},{"issue":"17","key":"3166_CR34","first-page":"2408","volume":"119","author":"MA Hlatky","year":"2009","unstructured":"Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, Go AS, Harrell FE Jr., Hong Y, Howard BV, et al. Criteria Evaluation Novel Markers Cardiovasc Risk: Sci Statement Am Heart Association Circulation. 2009;119(17):2408\u201316.","journal-title":"Criteria Evaluation Novel Markers Cardiovasc Risk: Sci Statement Am Heart Association Circulation"},{"issue":"4","key":"3166_CR35","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jval.2017.01.001","volume":"20","author":"A van Giessen","year":"2017","unstructured":"van Giessen A, Peters J, Wilcher B, Hyde C, Moons C, de Wit A, Koffijberg E. Systematic review of health economic impact evaluations of risk prediction models: stop developing, start evaluating. Value Health. 2017;20(4):718\u201326.","journal-title":"Value Health"},{"issue":"3","key":"3166_CR36","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jclinepi.2011.07.003","volume":"65","author":"L di Ferrante","year":"2012","unstructured":"di Ferrante L, Davenport C, Eisinga A, Hyde C, Deeks JJ. A capture-recapture analysis demonstrated that randomized controlled trials evaluating the impact of diagnostic tests on patient outcomes are rare. J Clin Epidemiol. 2012;65(3):282\u20137.","journal-title":"J Clin Epidemiol"},{"key":"3166_CR37","doi-asserted-by":"crossref","unstructured":"Kruiswijk AA, Engelhardt EG, Vlug LAE, van de Wal RJP, Schrage YM, Haas RL, van de Sande MAJ. P. J. Marang-van de Mheen, L. van Bodegom-Vos, Understanding how a personalized risk prediction tool (VALUE-PERSARC) supports informed treatment decisions of soft-tissue sarcomas patients in daily clinical practice \u2013 a mixed methods study. Eur J Cancer. 2024:114269.","DOI":"10.1016\/j.ejca.2024.114269"},{"issue":"2","key":"3166_CR38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/10775587070640020301","volume":"64","author":"E Peters","year":"2007","unstructured":"Peters E, Dieckmann N, Dixon A, Hibbard JH, Mertz CK. Less is more in presenting quality information to consumers. Med Care Res Rev. 2007;64(2):169\u201390.","journal-title":"Med Care Res Rev"},{"issue":"Suppl 2","key":"3166_CR39","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1186\/1472-6947-13-S2-S10","volume":"13","author":"KJ McCaffery","year":"2013","unstructured":"McCaffery KJ, Holmes-Rovner M, Smith SK, Rovner D, Nutbeam D, Clayman ML, Kelly-Blake K, Wolf MS, Sheridan SL. Addressing health literacy in patient decision aids. BMC Med Inf Decis Mak. 2013;13(Suppl 2):S10.","journal-title":"BMC Med Inf Decis Mak"},{"key":"3166_CR40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/1472-6963-13-301","volume":"13","author":"ME Branda","year":"2013","unstructured":"Branda ME, LeBlanc A, Shah ND, Tiedje K, Ruud K, Van Houten H, Pencille L, Kurland M, Yawn B, Montori VM. Shared decision making for patients with type 2 diabetes: a randomized trial in primary care. BMC Health Serv Res. 2013;13:301.","journal-title":"BMC Health Serv Res"},{"key":"3166_CR41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1748-5908-9-26","volume":"9","author":"KD Wyatt","year":"2014","unstructured":"Wyatt KD, Branda ME, Anderson RT, Pencille LJ, Montori VM, Hess EP, Ting HH, LeBlanc A. Peering into the black box: a meta-analysis of how clinicians use decision aids during clinical encounters. Implement Sci. 2014;9:26.","journal-title":"Implement Sci"},{"key":"3166_CR42","doi-asserted-by":"crossref","unstructured":"Ankersmid JW, Engelhardt EG, Lansink Rotgerink FK, The R, Strobbe LJA, Drossaert CHC, Siesling S, van Uden-Kraan CF. Evaluation of the implementation of the dutch breast cancer surveillance decision aid including personalized risk estimates in the SHOUT-BC study: a mixed methods approach. Cancers (Basel). 2024;16(7).","DOI":"10.3390\/cancers16071390"},{"key":"3166_CR43","doi-asserted-by":"publisher","first-page":"j1744","DOI":"10.1136\/bmj.j1744","volume":"357","author":"N Joseph-Williams","year":"2017","unstructured":"Joseph-Williams N, Lloyd A, Edwards A, Stobbart L, Tomson D, Macphail S, Dodd C, Brain K, Elwyn G, Thomson R. Implementing shared decision making in the NHS: lessons from the MAGIC programme. BMJ. 2017;357:j1744.","journal-title":"BMJ"},{"issue":"2","key":"3166_CR44","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1186\/1472-6947-13-S2-S12","volume":"13","author":"KR Sepucha","year":"2013","unstructured":"Sepucha KR, Borkhoff CM, Lally J, Levin CA, Matlock DD, Ng CJ, Ropka ME, Stacey D, Joseph-Williams N, Wills CE, et al. Establishing the effectiveness of patient decision aids: key constructs and measurement instruments. BMC Med Inf Decis Mak. 2013;13(2):S12.","journal-title":"BMC Med Inf Decis Mak"},{"issue":"1","key":"3166_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0272989X16657544","volume":"37","author":"AJ Vickers","year":"2017","unstructured":"Vickers AJ. Decisional conflict, regret, and the burden of rational decision making. Med Decis Making. 2017;37(1):3\u20135.","journal-title":"Med Decis Making"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-025-03166-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-025-03166-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-025-03166-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:24:20Z","timestamp":1759155860000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-025-03166-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3166"],"URL":"https:\/\/doi.org\/10.1186\/s12911-025-03166-6","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The VALUE-PERSARC study was approved by the Medical Ethical Committee Leiden-Den Haag-Delft (METC-LDD) (NL76563.058.21). Written informed consent was obtained from all participating patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"345"}}